Fusion Pharmaceuticals (NASDAQ: $FUSN), a Canadian biotech, has been acquired by British-Swedish Biotech giant AstraZeneca (NASDAQ: $AZN) in a $2.4 billion cash deal announced on […]
Category: Biotech
Moderna, Inc. (NASDAQ: $MRNA): Is the Biotech Giant Still a Buy in 2024 After COVID-19 Vaccine Success?
Moderna, Inc. (NASDAQ: $MRNA) has come a long way since its early days as a relatively unknown biotech company. Founded in 2010, the Cambridge, Massachusetts-based […]
Novavax (NASDAQ: $NVAX) Declines Over 20% After Disappointing Q4 Results
Novavax (NASDAQ: $NVAX) is an American biotech company that focuses on developing vaccines to stop infectious diseases. One of its vaccines, Nuvaxovid, was approved in […]
Clearmind Medicine’s (NASDAQ: $CMND) Promising Meeting with FDA Boosts Prospects for Innovative Alcohol Addiction Treatment
Clearmind Medicine Inc. (NASDAQ: $CMND), a biotech company, is developing novel psychedelic-based therapies to treat alcohol use disorder (AUD), like binge drinking where current treatment […]
Voyager Therapeutics Inc (NASDAQ: $VYGR) Stock Value Surges Following $1.2 Billion Agreement with Novartis
Voyager Therapeutics (NASDAQ: $VYGR) is a pioneer biotechnology company with a prime focus on developing treatments for severe neurological diseases. Moreover, the company has advanced […]
CRISPR Therapeutics AG (NASDAQ: $CRSP) Gets Green Light to Commercialize Their Gene Therapy for Sickle Cell Disease
CRISPR Therapeutics AG (NASDAQ: CRSP) is a leader in gene editing technology. The company is working on cures for serious diseases using its proprietary gene-editing […]